ARCHIVES

FDA Grants Priority Review To Two Drugs in NSCLC

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation

November 22, 1991

ODAC Discussion: NCI’s Richard Simon Cautions About Rules Of Thumb

January 30, 2009

Cancer Research Emphasis Grants (CREG) Offered As A New Way To Fund Contract Research Efforts

November 23, 1974

Bladder Cancer Survival Rate Rises With Neoadjuvant Chemo

September 26, 2003

Center Studies Prevention For Endometrial Cancer

February 25, 2005

In Brief: Cavanee Succeeds Coffey As AACR President; Von Hoff Is President-Elect; Awards Presented

April 10, 1998